On October 23, 2014, the Canadian government introduced an omnibus budget bill.
November 10, 2014
Bill C-17, An Act to Amend the Food and Drugs Act, has now passed through Parliament and was given Royal Assent on November 6, 2014.
November 07, 2014
The Federal Court of Appeal allowed Janssen’s appeals of three decisions of Mr. Justice Hughes that resulted in an injunction order against Janssen.
November 03, 2014
The Supreme Court of Canada announced yesterday that it has granted leave to appeal the decision of the Federal Court of Appeal in a proceeding commenced by Apotex.
October 31, 2014
The report of consultant, IBM Healthcare, contracted under the direction of the Ontario Ministry of Health and Long-Term Care has been publicly released.
October 28, 2014
On October 23, the Minister of National Revenue (the Minister) filed Notices of Application in the Federal Court against a number of generic drug manufacturers.
October 27, 2014
The Competition Bureau made several significant announcements in September that affect the pharmaceuticals and life sciences sectors.
October 02, 2014
On September 26, 2014, after five years of negotiations, the Comprehensive Economic and Trade Agreement (CETA) consolidated text was finally released to the public.
October 01, 2014
In the last decade, the expansion of research in genetics, genomics and other healthcare approaches has allowed physicians to customize medical treatment.
September 25, 2014
Canada is one of the few developed countries without a specific regulatory framework for drugs for rare diseases, often termed “orphan drugs”.
September 10, 2014
Try searching our global site instead